Reducing the individual and societal burden of diabetes mellitus based on interdisciplinary research – the main objective of DDZ
The distinctive feature of DDZ is the translational networking of molecular and cell biological fundamental research with clinical and epidemiological health care-related research. The aim of the scientific contributions is to improve the prevention, early detection, diagnosis, and therapy of diabetes mellitus and its comorbidities and complications as well as the data on epidemiology and health economics of diabetes in Germany, while taking into account the perspective of people affected by diabetes. In addition, the DDZ is the Leibniz Association’s reference center for diabetes.
In this capacity, the DDZ provides scientific information about diabetes mellitus and acts as the liaison for all parties involved in the healthcare system.
Institutes & Research Areas
- Institute for Clinical DiabetologyMechanisms of development of type 1 or type 2 diabetes with its sequelae. Studies on the prevention, use of new drugs and treatment of late complications
- Institute for Clinical Biochemistry and PathobiochemistryResearch into the molecular basis of diabetes mellitus to improve its prevention, prediction and therapy
- Institute for Biometrics and EpidemiologyPopulation-based studies to improve prevention and care
- Institute for Vascular and Islet Cell BiologyFundamentals of pancreatic islets and blood vessels - Development of new drugs and therapies for the treatment of diabetes and its cardiovascular consequences
- Institute for Health Services Research and Health EconomicsEvaluation of clinical and cost effectiveness of prevention and care. Special consideration of everyday care and patient perspective
- National Diabetes Information CenterQuality-assured and independent information on issues around diabetes for the general public, doctors and professionals